These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Use of polyvinylpyridine N-oxide for treating experimental silicosis and anthracosilicosis]. Deĭnega VG, Bolonova LN, Sukhanov VV, Zemliakova LF, Tkachuk SV. Gig Tr Prof Zabol; 1977 Nov; (6):25-8. PubMed ID: 892540 [No Abstract] [Full Text] [Related]
4. [Effect of inhalations of polyvinylpyridine-N-oxide on the development of experimental silicosis]. Rodkina BS, Bolonova LN. Farmakol Toksikol; 1979 Nov; 42(1):81-4. PubMed ID: 421895 [Abstract] [Full Text] [Related]
14. [Changes induced by poly-2-vinylpyridine-N-oxide in susceptibility of macrophages to tubercular infection]. Briatico-Vangosa G, Chiappino G. Med Lav; 1973 Nov; 64(7):283-7. PubMed ID: 4208311 [No Abstract] [Full Text] [Related]
15. [Decomposition of collagen in experimental silicosis following treatment with polyvinylpyridine-N-oxide in dependence on the dosage]. Pott F, Dehnen W, Brockhaus A. Beitr Klin Erforsch Tuberk Lungenkr; 1970 Nov; 140(3):259-67. PubMed ID: 4314381 [No Abstract] [Full Text] [Related]
16. [CC1-4 detoxication by poly-2-vinylpyridine-N-oxide in rats]. Antweiler H, Dehnen W. Naunyn Schmiedebergs Arch Pharmakol; 1970 Nov; 266(4):290-1. PubMed ID: 4253735 [No Abstract] [Full Text] [Related]